Skip to main content

Articles

Page 19 of 22

  1. Authors: Franziska Werner, Katharina Völker, Claus-Jürgen Scholz, Margarethe Goebel, Michael Seimetz, Baktybek Kojonazarov, Kai Schuh, Bhola K Dahal, Ralph T Schermuly, Heike Oberwinkler, Birgit Gaßner and Michaela Kuhn
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P77

    This article is part of a Supplement: Volume 14 Supplement 1

  2. Authors: Sergei D Rybalkin, Masami Shimizu, Irina G Rybalkina, Enrico Patrucco, Kenneth Bible, Elina Minami, Jennifer O'Brien, Lawrence P Wennogle, Franz Hofmann, Joseph A Beavo and Stanley C Froehner
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O38

    This article is part of a Supplement: Volume 14 Supplement 1

  3. Authors: Soo Ghim Lim, S Jeson Sangaralingham, Syed Ameenuddin, Fernando L Martin, Xu Wen Ng, Ying Ying Huang, Subbu S Venkatraman, John C Burnett Jr and Horng H Chen
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P38

    This article is part of a Supplement: Volume 14 Supplement 1

  4. Authors: Roland Seifert, Christina Hartwig, Sabine Wolter, Daniel Reinecke, Heike Burhenne, Volkhard Kaever, Antje Munder, Burkhard Tümmler, Frank Schwede, Manuel Grundmann, Evi Kostenis, Dara W Frank and Ulrike Beckert
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O36

    This article is part of a Supplement: Volume 14 Supplement 1

  5. Authors: Sabine Klein, Barbara Seidler, Anna Kettenberger, Andrei Sibaev, Robert Feil, Franz Hofmann, Jean-Marie Vanderwinden, Hans-Dieter Allescher, Michael Schemann, Martin A Storr, Roland M Schmid, Günter Schneider and Dieter Saur
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P34

    This article is part of a Supplement: Volume 14 Supplement 1

  6. Authors: Sabine Klein, Barbara Seidler, Anna Kettenberger, Andrei Sibaev, Michael Rohn, Robert Feil, Hans-Dieter Allescher, Jean-Marie Vanderwinden, Franz Hofmann, Michael Schemann, Roland Rad, Martin A Storr, Roland M Schmid, Günter Schneider and Dieter Saur
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O30

    This article is part of a Supplement: Volume 14 Supplement 1

  7. Authors: Gilbert Y Huang, Jeong J Kim, Albert S Reger, Robin Lorenz, Eui-Whan Moon, Chi Zhao, Darren E Casteel, Daniela Bertinetti, Bryan VanSchouwen, Rajeevan Selvaratnam, James W Pflugrath, Banumathi Sankaran, Giuseppe Melacini, Friedrich W Herberg and Choel Kim
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O16

    This article is part of a Supplement: Volume 14 Supplement 1

  8. Authors: Loek van Heerebeek, Nazha Hamdani, Inês Falcão-Pires, Adelino F Leite-Moreira, Mark PV Begieneman, Jean GF Bronzwaer, Jolanda van der Velden, Ger JM Stienen, Gerrit J Laarman, Aernout Somsen, Freek WA Verheugt, Hans WM Niessen and Walter J Paulus
    Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O2

    This article is part of a Supplement: Volume 14 Supplement 1

  9. There are many reports of cognitive dysfunction in patients receiving chemotherapy or targeted therapies. Many antineoplastic agents may be involved in the condition also known as “chemo brain” or “chemo fog”.

    Authors: Adeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, Marie-Anne Mackowiak, Pierre Lenfant, Marie-Pierre Noel, Thierry Facon, Xavier Leleu, Florence Pasquier and Emilie Le Rhun
    Citation: BMC Pharmacology and Toxicology 2013 14:41
  10. Anakinra pharmacokinetics and pharmacodynamics were investigated in children and adolescents treated for systemic-onset juvenile idiopathic arthritis (SJIA) and autoinflammatory syndromes.

    Authors: Saik Urien, Christophe Bardin, Brigitte Bader-Meunier, Richard Mouy, Sandrine Compeyrot-Lacassagne, Franz Foissac, Benoît Florkin, Carine Wouters, Bénédicte Neven, Jean-Marc Treluyer and Pierre Quartier
    Citation: BMC Pharmacology and Toxicology 2013 14:40
  11. The aim of this study was to assess the association between prescription changes frequency (PCF) and hospital admissions and to compare the PCF to the Chronic Disease Score (CDS). The CDS measures comorbidity ...

    Authors: Carolien GM Sino, Rutger Stuffken, Eibert R Heerdink, Marieke J Schuurmans, Patrick C Souverein and Toine (A) CG Egberts
    Citation: BMC Pharmacology and Toxicology 2013 14:39
  12. Olanzapine use has been reported during pregnancy and breastfeeding, but there are no controlled clinical trials assessing the safety of olanzapine exposure to infants and fetuses. The purpose of this report w...

    Authors: Elizabeth Brunner, Deborah M Falk, Meghan Jones, Debashish K Dey and Chetan Chinmaya Shatapathy
    Citation: BMC Pharmacology and Toxicology 2013 14:38
  13. The γ-aminobutyric acid (GABA) type A receptor (GABAAR) contains the recognition sites for a variety of agents used in the treatment of brain disorders, including anxiety and epilepsy. A better understanding of h...

    Authors: Shamol Saha, Yinghui Hu, Stella C Martin, Sabita Bandyopadhyay, Shelley J Russek and David H Farb
    Citation: BMC Pharmacology and Toxicology 2013 14:37
  14. Casein kinase 2 (CK2) is involved in various cellular events such as proliferation, apoptosis, and the cell cycle. CK2 overexpression is associated with multiple human cancers and may therefore be a promising ...

    Authors: Shu Liu, David Hsieh, Yi-Lin Yang, Zhidong Xu, Csaba Peto, David M Jablons and Liang You
    Citation: BMC Pharmacology and Toxicology 2013 14:36
  15. Amphetamine and amphetamine derivatives are suggested to induce an immunosuppressive effect. However, knowledge of how amphetamines modulate intracellular signaling pathways in cells of the immune system is li...

    Authors: Therese Bredholt, Elisabeth Ersvær, Bjarte Skoe Erikstein, André Sulen, Håkon Reikvam, Hans Jørgen Aarstad, Anne Christine Johannessen, Olav Karsten Vintermyr, Øystein Bruserud and Bjørn Tore Gjertsen
    Citation: BMC Pharmacology and Toxicology 2013 14:35
  16. The use of substandard and degraded medicines is a major public health problem in developing countries such as Cambodia. A collaborative study was conducted to evaluate the quality of amoxicillin–clavulanic ac...

    Authors: Mohiuddin Hussain Khan, Kirara Hatanaka, Tey Sovannarith, Nam Nivanna, Lidia Cecilia Cadena Casas, Naoko Yoshida, Hirohito Tsuboi, Tsuyoshi Tanimoto and Kazuko Kimura
    Citation: BMC Pharmacology and Toxicology 2013 14:33
  17. Dormant cells are characterised by low RNA synthesis. In contrast, cancer cells can be addicted to high RNA synthesis, including synthesis of survival molecules. We hypothesised that dormant cancer cells, alre...

    Authors: Monica Pallis, Francis Burrows, Abigail Whittall, Nicholas Boddy, Claire Seedhouse and Nigel Russell
    Citation: BMC Pharmacology and Toxicology 2013 14:32
  18. Protein-Protein Interactions (PPIs) are key for many cellular processes. The characterization of PPI interfaces and the prediction of putative ligand binding sites and hot spot residues are essential to design...

    Authors: Adriana Isvoran, Dana Craciun, Virginie Martiny, Olivier Sperandio and Maria A Miteva
    Citation: BMC Pharmacology and Toxicology 2013 14:31
  19. Infectious diseases are major public health problem. It is increasingly affecting more than 50 million people worldwide. Targeting shikimate pathway could be efficiently used for the development of broad spect...

    Authors: Prabakaran Pitchandi, Waheeta Hopper and Rathankar Rao
    Citation: BMC Pharmacology and Toxicology 2013 14:29
  20. The role of G protein-coupled receptor (GPR40), which is highly expressed in pancreatic beta cells, has been studied extensively in the amelioration of beta cell dysfunction in T2D using rat and mouse islets, ...

    Authors: Nagesh Gowda, Anilkumar Dandu, Jaideep Singh, Sanghamitra Biswas, Vijaya Raghav, Mudigere N Lakshmi, Pavagada C Shilpa, Venkategowda Sunil, Ashokkumar Reddy, Manojkumar Sadasivuni, Kumaraswamy Aparna, Mahesh Kumar Verma, Yoganand Moolemath, Mammen O Anup, Marikunte V Venkataranganna, Baggavalli P Somesh…
    Citation: BMC Pharmacology and Toxicology 2013 14:28
Reviewer acknowledgments

Annual Journal Metrics

  • Citation Impact
    2.605 - 2-year Impact Factor (2021)
    2.943 - 5-year Impact Factor (2021)
    0.953 - SNIP (Source Normalized Impact per Paper)
    0.497 - SJR (SCImago Journal Rank)

    Speed
    42 days to first decision for all manuscripts (Median)
    59 days to first decision for reviewed manuscripts only (Median)

    Usage 
    588,461 Downloads (2021)
    402 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal